Expertise in
1
conditions

Natalie Schub

Kiel, SH, DE 
Expertise in
1
conditions
Kiel, SH, DE 

Overview

Natalie Schub practices practicing medicine in Kiel, Germany.

Ms. Schub is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Multiple Myeloma, Neurotoxicity Syndromes, Non-Hodgkin Lymphoma, Graft Versus Host Disease (GvHD), and Bone Marrow Transplant.

She is actively involved in clinical research, co-authoring 26 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Kiel, SH, Germany
Other Locations
Luebeck, SH 23538, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase I/II, Randomized, Open-label Platform Study Utilizing a Master Protocol to Study Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Anti-Cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) - DREAMM 5
A Phase I/II, Randomized, Open-label Platform Study Utilizing a Master Protocol to Study Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Anti-Cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) - DREAMM 5
Enrollment Status: Active_not_recruiting
Publish Date: May 06, 2026
Intervention Type: Drug
Study Drugs: Belantamab Mafodotin, GSK3174998, Feladilimab, Nirogacestat, Dostarlimab, Isatuximab
Study Phase: Phase 1/Phase 2

26 Total Publications

Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.
Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.
Journal: Nature medicine
Published: July 06, 2026

Frequently Asked Questions about Natalie Schub

Is Natalie Schub a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Natalie Schub is classified as an Advanced expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Natalie Schub participate in research or clinical trials?

Yes. Natalie Schub has published 26 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Natalie Schub's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Schub's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile